L1 Covid Vaccines Flashcards

1
Q

What are coronaviruses?

A

Diverse family of enveloped positive-sense single-stranded RNA viruses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the biology and pathogenesis of SARS-Cov2 similar to?

A

SARS & MERS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What was covid 19 caused by?

A

SARS-Cov2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

When can viruses replicate?

A

Within human cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What does the spike protein allow for?

A

essential for attachment & entry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What receptor does the virus’ spike protein lock on to?

A

ACE2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

When is the virus hidden from the immune system?

A

Within the cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What cells engulf the virus?

A

APC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the B cell response?

A

Development of antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What immune cells destroy virus-infected cells?

A

T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What response do you get in natural infection?

A

Secretory IgA response in nasal cavity
IgG1 (circulatory) in lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What response was the intradermal vaccination good at developing?

A

IgG response
not good at slgA1 response as nasal never exposed to antigen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the downside of the intranasal vaccine?

A

Does not translate to other regions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is a real difficulty for vaccines?

A

Stopping transmission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are 4 protein vaccine targets?

A

Spike proteins
membrane
envelope
nucleocapsid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why did they not look at other proteins after the spike protein?

A

Poor immunogenicity from M+E proteins
N protein vaccination caused serious issues (inappropriate immune response)

17
Q

What are 4 challenges with vaccine development?

A

Around for a long time as transient infections
Mutate and evolve in real time
How quickly can you implement global vaccination program?
How can you regulate a vaccine in an emergency situation?

18
Q

Why did normal processes change for covid vaccine?

A

Political pressure on regulatory system

19
Q

What was changed in the vaccine development by FDA?

A

Didn’t have to finish phase I before phase II - allowed for overlap - reduced 15 yr process

20
Q

Why was there a large variety of different types of vaccines?

A
  • each company had their own vaccine platforms
21
Q

What are 2 main aims of vaccine?

A

Elicit immune response
reduce symptoms

22
Q

What is RBD?

A

Receptor binding domain

23
Q

What are 6 examples of vaccines?

A

RBD of spike protein
Recombinant spike-protein-based vaccines
VLPs
Replication incompetent/competent
Nuclei acid based
inactivated virus vector

24
Q

What type of vaccine dominate?

A

RNA vaccines - easy to manufacture as they are non-protein based

25
Q

What is an example of a non-replicating viral vector?

A

Adenovirus eg. Astrazeneca

26
Q

What are characteristics of the AstraZeneca vaccine?

A

single dose
66% protection
good results overall

27
Q

What are characteristics of Pfizer vaccine?

A

2 dose
-70 storage
95% effective
mostly used in ireland

28
Q

What are characteristics of Novavax?

A

2 dose
recombinant spike-protein-based
Matrix-M adjuvant
90% effective

29
Q

How did new variants compare to original stain?

A

New variants were more transmissible but less pathogenic

30
Q

What is a pan vaccine?

A

Vaccine effective against all coronavirus variants and previous strains

31
Q

What were ethical considerations?

A

Supply and demand
vaccine equity
equitable distribution
vaccine hesitancy

32
Q

How many doses were needed?

A

16bn doses

33
Q

Were vaccines rolled out evenly on a global scale?

34
Q

What were the top 4 countries with vaccination rate in Europe?

A

Malta
Denmark
Italy
Ireland

35
Q

What is a serious implication of vaccine hesitancy?

A

Health services as non-vaccinated individuals most more likely to take up ICU spaces

36
Q

What variant showed waning immunity?

A

Delta variant

37
Q

Why weren’t children vaccinated?

A

didn’t develop serious disease - problem if there is an outbreak with a new variant

38
Q

What are therapeutics?

A

classical anti-viral drugs targeting RNA dependent RNA polymerase or protease

39
Q

Whats an example of therapeutics?

A

Mpro inhibitors (Remdesivir)
RdRp inhibitors (Paxlovid)